Efficacy and Safety of Ustekinumab for Ulcerative Colitis Through 3 Years: UNIFI Long-term Extension

被引：0
|
作者：
Abreu, M. T.
Danese, S.
Sandborn, W. J.
Miao, Y.
Tikhonov, I.
Zhang, H.
Panacciones, R.
Hisamatsu, T.
Scherl, E. J.
Leong, R. W.
Rowbotham, D. S.
Arasaradnam, R. P.
Afif, W.
Peyrin-Biroulet, L.
Sands, B. E.
Marano, C.
机构：
来源：
JOURNAL OF CROHNS & COLITIS | 2021年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
DOP83
引用
收藏
页码：S113 / S114
页数：4
相关论文
共 50 条
  • [21] Efficacy and safety of ustekinumab as maintenance therapy in ulcerative colitis: Week 44 results from UNIFI
    Sandborn, W. J.
    Sands, B. E.
    Panaccione, R.
    O'Brien, C. D.
    Zhang, H.
    Johanns, J.
    Peyrin-Biroulet, L.
    Van Assche, G.
    Danese, S.
    Targan, S. R.
    Abreu, M. T.
    Hisamatsu, T.
    Szapary, P.
    Marano, C.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S26 - S26
  • [22] EFFICACY AND SAFETY OF USTEKINUMAB THROUGH WEEK 16 IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS RANDOMIZED TO USTEKINUMAB: RESULTS FROM THE UNIFI INDUCTION TRIAL
    Danese, Silvio
    Sands, Bruce E.
    O'Brien, Christopher D.
    Zhang, Hongyan
    Johanns, Jewel
    Sloan, Sheldon
    Izanec, James L.
    Szapary, Philippe
    Marano, Colleen W.
    Leong, Rupert W.
    Rowbotham, David
    Targan, Stephan R.
    Van Assche, Gert A.
    GASTROENTEROLOGY, 2019, 156 (06) : S1106 - S1106
  • [23] Efficacy and Safety of Ustekinumab for Crohn's Disease: Results From IM-UNITI Long-Term Extension Through 3 Years
    Sandborn, William J.
    Rutgeerts, Paul
    Jacobstein, Douglas
    Gasink, Christopher
    Patel, Reese
    Zou, Bin
    Johanns, Jewel
    Sands, Bruce E.
    Hanauer, Stephen
    Targan, Stephan
    Ghosh, Subrata
    de Villiers, Willem
    Colombel, Jean-Frederic
    Feagan, Brian
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S345 - S346
  • [24] ECCO 2023: New Long-term Data presented on the Efficacy of Ustekinumab in Ulcerative colitis and the Safety Profile of Ustekinumab in Crohn's Disease (CD) and Ulcerative colitis (UC)
    不详
    VISCERAL MEDICINE, 2023, 39 (3-4) : 98 - 98
  • [25] Efficacy and safety of ustekinumab as maintenance therapy in ulcerative colitis: Week 44 results from the UNIFI study
    Sands, B.
    Sandborn, W.
    Pannacione, R.
    O'Brien, C.
    Leong, R.
    Zhang, H.
    Johanns, J.
    Peyrin-Biroulet, L.
    Van Assche, G.
    Danese, S.
    Targan, S.
    Abreu, M.
    Hisamatsu, T.
    Szapary, P.
    Marano, C.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 129 - 130
  • [26] LONG-TERM EFFICACY AND SAFETY OF USTEKINUMAB FOR CROHN'S DISEASE: RESULTS FROM IM-UNITI LONG-TERM EXTENSION THROUGH TWO YEARS
    Sandborn, William J.
    Rutgeerts, Paul
    Gasink, Christopher
    Jacobstein, Douglas
    Gao, Long-Long
    Johanns, Jewel
    Sands, Bruce E.
    Hanauer, Stephen B.
    Targan, Stephan R.
    Ghosh, Subrata
    de Villiers, Willem J.
    Colombel, Jean Frederic
    Feagan, Brian G.
    GASTROENTEROLOGY, 2017, 152 (05) : S585 - S585
  • [27] Efficacy and Safety of Ustekinumab (UST) as Maintenance Therapy in Ulcerative Colitis: Week 44 Results from UNIFI
    Marone, Colleen
    Sandborn, William J.
    Sands, Bruce E.
    Panaccione, Remo
    O'Brien, Christopher D.
    Zhang, Hongyan
    Johanns, Jewel
    Peyrin-Biroulet, Laurent
    van Assche, Gert
    Danese, Silvio
    Targan, Stephan
    Abreu, Maria T.
    Hisamatsu, Tadakazu
    Szapary, Philippe
    SWISS MEDICAL WEEKLY, 2019, : 27S - 27S
  • [28] Long-term safety and efficacy of budesonide in the treatment of ulcerative colitis
    Iborra, Marisa
    Alvarez-Sotomayor, Diego
    Nos, Pilar
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2014, 7 : 39 - 46
  • [29] Efficacy and safety of ustekinumab through Week 16 in patients with moderate-to-severe ulcerative colitis randomised to ustekinumab: results from the UNIFI induction trial
    Danese, S.
    Sands, B. E.
    O'Brien, C. D.
    Zhang, H.
    Johanns, J.
    Sloan, S.
    Izanec, J.
    Szapary, P.
    Marano, C.
    Leong, R. W.
    Rowbotham, D.
    Targan, S. R.
    Van Assche, G.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S61 - S62
  • [30] Efficacy and safety of ustekinumab through Week 16 in patients with moderate to severe ulcerative colitis: Results from the UNIFI induction trial
    Danese, S.
    Sands, B.
    O'Brien, C.
    Zhang, H.
    Johanns, J.
    Sloan, S.
    Izanek, J.
    Szapary, P.
    Marano, C.
    Leong, R.
    Rowbotham, D.
    Targan, S.
    Van Assche, G.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 130 - 131
12345